Status:
UNKNOWN
Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Lead Sponsor:
Hartford Hospital
Conditions:
Impotence
Prostatic Neoplasms
Eligibility:
MALE
40-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if adding hyperbaric oxygen therapy, a therapy that delivers oxygen under slight pressure, to a drug treatment of PDE5I (such as Viagra, Levitra, Cialis)for m...
Detailed Description
Prostate cancer is the most common non-skin malignancy in men in the United States, with approximately 232,000 diagnoses of adenocarcinoma projected for 2005. More than 150,000 of these men are treate...
Eligibility Criteria
Inclusion
- male
- age 40-69
- diagnosis of Stage I prostate cancer
- bilateral NSRRP as primary treatment
- sexual potency prior to surgery
Exclusion
- COPD, CHF, diabetes mellitus
- known inability to tolerate PDE5I
- confinement anxiety/claustrophobia
- planned adjuvant or neo-adjuvant therapy
- patients taking alpha blockers or nitrates
- patients with retinitis pigmentosa
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00906269
Start Date
July 1 2009
End Date
January 1 2021
Last Update
May 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06106